Ranolazine | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ranolazine
Europe

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 27 USDMF, 16 EU WC, 2 KDMF, 22 NDC API, 35 Listed Suppliers, $ API Reference Price

56 API Suppliers
27 USDMF
16 EU WC
2 KDMF
22 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

52 Drugs in Development

52 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 58 FDA Orange Book, 28 Europe, 2 Canada, 3 South Africa, 23 Listed Dossiers

114 FDF Dossiers
58 FDA Orange Book
28 Europe
2 Canada
3 South Africa
23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GRANULES, EXTENDED RELEASE;ORAL - 1GM
GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 SPI Pharma, 4 DKSH, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 9 Ideal Cures, 21 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 26 Controlled & Modified Release, 14 Solubilizers, 14 Direct Compression, 14 Thickeners and Stabilizers, 13 Granulation, 12 Film Formers & Plasticizers, 12 Lubricants & Glidants, 10 Parenteral, 9 Co-Processed Excipients, 7 Topical, 6 Disintegrants & Superdisintegrants, 6 Taste Masking, 6 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 4 Chewable & Orodispersible Aids

59 Coating Systems & Additives
32 Fillers, Diluents & Binders
26 Controlled & Modified Release
14 Solubilizers
14 Direct Compression
14 Thickeners and Stabilizers
13 Granulation
12 Film Formers & Plasticizers
12 Lubricants & Glidants
10 Parenteral
9 Co-Processed Excipients
7 Topical
6 Disintegrants & Superdisintegrants
6 Taste Masking
6 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Coloring Agents
4 Chewable & Orodispersible Aids

DIGITAL CONTENT

27 News #PharmaBuzz

27 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 25 Regulatory FDF Prices, 8 Annual Reports

19 US Medicaid Prescriptions
25 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

10 Others

10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 76 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

28 All

01 6A. Menarini GmbH

02 3ADAMED SRL

03 3DOC GENERICI SRL

04 3EG SPA

05 3KRKA DDNOVO MESTO

06 3MENARINI INTERNAT. O.L.S.A

07 3MENARINI INTERNAT. OLSA

08 3Menarini International

09 1Viatris Pharma GmbH

filter Active Ingredients Reset all filters

28 All

01 1Acidum tranexamicum

02 18Ranolazine

03 6Ranolazinum

04 3ranolazine

filter Dosage Form Reset all filters

28 All

01 3Extended Release Tablet

02 12Extended Release Tablets

03 3PROLONGED-RELEASE TABLET

04 1Ranolazina 375Mg 60 Units Oral Use Rp

05 1Ranolazina 500Mg 60 Units Oral Use Rp

06 1Ranolazina 750Mg 60 Units Oral Use Rp

07 3Ret Tabl

08 3Ret Tablet

09 1Tabl

filter Country Reset all filters

28 All

01 18Italy

02 3Sweden

03 7Switzerland

filter Brand Name Reset all filters

28 All

01 1Cyclokapron

02 3RANEXA

03 3RANOLAZINA DOC GENERIC

04 3RANOLAZINA EG

05 3RANOLAZINA KRKA

06 3RANOZEK

07 12Ranexa

List of Suppliers

Product Main Page

01

ADAMED SRL

Coatings Trends

Not Confirmed

ADAMED SRL

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : RANOZEK

Dosage Form : Extended Release Tablets

Dosage Strength : 375 mg

Packaging : 60 UNITS 375 MG - ORAL USE (PROLONGED RELEASE)

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ADAMED SRL

Coatings Trends

Not Confirmed

ADAMED SRL

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : RANOZEK

Dosage Form : Extended Release Tablets

Dosage Strength : 500 mg

Packaging : 60 UNITS 500 MG - ORAL USE (PROLONGED RELEASE)

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ADAMED SRL

Coatings Trends

Not Confirmed

ADAMED SRL

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : RANOZEK

Dosage Form : Extended Release Tablets

Dosage Strength : 750 mg

Packaging : 60 UNITS 750 MG - ORAL USE (PROLONGED RELEASE)

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

DOC GENERICI SRL

Coatings Trends

Not Confirmed

DOC GENERICI SRL

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : RANOLAZINA DOC GENERIC

Dosage Form : Extended Release Tablets

Dosage Strength : 375 mg

Packaging : 60 UNITS 375 MG - ORAL USE (PROLONGED RELEASE)

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Menarini International

Coatings Trends

Not Confirmed

Menarini International

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Ranexa

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 375 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Menarini International

Coatings Trends

Not Confirmed

Menarini International

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Ranexa

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 500 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Menarini International

Coatings Trends

Not Confirmed

Menarini International

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Sweden

Brand Name : Ranexa

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 750 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Ranexa

Dosage Form : Ranolazina 375Mg 60 Units Oral Use Rp

Dosage Strength : 60 CPR 375 mg prolonged release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Ranexa

Dosage Form : Ranolazina 500Mg 60 Units Oral Use Rp

Dosage Strength : 60 CPR 500 mg prolonged release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

MENARINI INTERNAT. O.L.S.A

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Italy

Brand Name : Ranexa

Dosage Form : Ranolazina 750Mg 60 Units Oral Use Rp

Dosage Strength : 60 CPR 750 mg prolonged release

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!